title: Effects of feeding fish oil on the properties of lipoproteins isolated from rhesus monkeys consuming an atherogenic diet.
abstract: This study examined plasma lipids and lipoproteins of rhesus monkeys fed fish oil incorporated into a highly atherogenic diet containing saturated fat and cholesterol. The animals were fed diets containing 2% cholesterol and either 25% coconut oil (group I), 25% fish oil/coconut oil (1:1; group II), or 25% fish oil/coconut oil (3:1; group III) for 12 months (n = 8/group). Adding menhaden fish oil to the diet increased plasma eicosapentaenoic acid and docosahexaenoic acid and decreased plasma linoleic acid in animals fed the fish oil containing diets. Plasma concentrations of all lipoprotein fractions were decreased in the fish oil groups. VLDL isolated from group I animals exhibited beta-mobility on agarose gels but the VLDL from groups II and III animals did not. The group I VLDL was more highly enriched in cholesteryl ester than was VLDL from groups II and III. Group I LDL had a small but significant increase in cholesteryl ester content compared to group III LDL. No differences in HDL composition were observed in the 3 groups. At least 6 times less apo E was recovered in VLDL, IDL, and LDL from group III animals than from group I animals. Assuming 1 molecule of apo B per lipoprotein particle, there were 50% fewer VLDL, IDL, and LDL particles in group III than in group I animals. Group III also had significantly lower molar ratios of apo E/apo B in VLDL, IDL, and LDL than did group I animals. When VLDL from all 3 groups were incubated with J774 macrophages at equal protein concentrations, only the VLDL from the group I animals stimulated cholesterol esterification. Thus, introducing fish oil into an atherogenic diet reduced the number of VLDL, IDL and LDL particles in plasma by as much as 50%, reduced the cholesteryl ester content of the circulating lipoprotein, and reduced the ability of the VLDL to stimulate cholesterol esterification in macrophages.
authors.affiliation: Department of Pathology, University of Chicago, IL 60637.
authors.forename: P A
authors.initials: PA
authors.lastname: Soltys
authors.forename: T
authors.initials: T
authors.lastname: Mazzone
authors.forename: R W
authors.initials: RW
authors.lastname: Wissler
authors.forename: S
authors.initials: S
authors.lastname: Vahed
authors.forename: V
authors.initials: V
authors.lastname: Rangnekar
authors.forename: J
authors.initials: J
authors.lastname: Lukens
authors.forename: D
authors.initials: D
authors.lastname: Vesselinovitch
authors.forename: G S
authors.initials: GS
authors.lastname: Getz
mesh_terms: D000818:Animals; D001055:Apolipoproteins B / Q000097:blood; D001057:Apolipoproteins E / Q000097:blood; D001161:Arteriosclerosis / Q000378:metabolism; D002788:Cholesterol Esters; D004036:Diet, Atherogenic; D005395:Fish Oils / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood* / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000097:blood; D008253:Macaca mulatta; D008264:Macrophages / Q000378:metabolism
chemical_list: D001055:Apolipoproteins B; D001057:Apolipoproteins E; D002788:Cholesterol Esters; D005395:Fish Oils; D008074:Lipoproteins; D008079:Lipoproteins, VLDL